# PRZO (ParaZero Technologies Ltd.) - SEC EDGAR Financial Statements

> ParaZero Technologies Ltd. reported $1.05M in revenue and a net loss of $5.41M for the fiscal year ended December 31, 2025 (up 12.3% year over year), with a 4.8% gross margin and a -721.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/PRZO
- Markdown: https://convexityos.com/fundamentals/PRZO.md
- SEC CIK: 0001916241
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001916241&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $1.05M | +12.3% YoY |
| Operating Income | FY 2025 | -$7.55M | -721.1% margin |
| Net Income | FY 2025 | -$5.41M | -517.1% net margin |
| Diluted EPS | FY 2025 | $0.31 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$5.83M | -557.2% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $4.16M | Total debt: $307K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.05M | $932K | $621K | $560K | $724K |
| Cost of Revenue | $997K | $874K | $477K | $338K | $465K |
| **Gross Profit** | $50K | $58K | $144K | $223K | $260K |
| Research & Development | $2.34M | $2.14M | $637K | $640K | $604K |
| Selling, General & Admin | $5.26M | $3.48M | $1.96M | $1.03M | $643K |
| **Operating Income** | -$7.55M | -$5.57M | -$2.80M | -$1.84M | -$987K |
| **EBITDA** | -$7.52M | -$5.54M | -$2.78M | -$1.82M | -$970K |
| Interest Expense | -- | -- | $153K | $17K | -- |
| **Net Income** | -$5.41M | -$11.05M | -$3.77M | -$1.65M | -$615K |
| Basic EPS | $0.31 | $0.99 | $0.77 | $0.49 | $1.71 |
| **Diluted EPS** | $0.31 | $0.99 | $0.77 | $0.49 | $1.71 |
| Basic Shares Outstanding | 17.5M | 11.1M | 4.9M | 3.3M | 359.7K |
| Diluted Shares Outstanding | 17.5M | 11.1M | 4.9M | 3.3M | 359.7K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.16M | $4.18M | $7.43M | $90K |
| Short-Term Investments | $2.00M | -- | -- | -- |
| **Cash & Short-Term Investments** | $4.20M | $4.18M | $7.43M | $90K |
| Accounts Receivable, Net | $185K | $115K | $22K | $184K |
| Inventory | $204K | $394K | $264K | $305K |
| Other Current Assets | $283K | $422K | $652K | $180K |
| **Total Current Assets** | $4.83M | $5.11M | $8.37M | $1.05M |
| Property, Plant & Equipment, Net | $106K | $108K | $50K | $41K |
| **Total Non-Current Assets** | $473K | $628K | $58K | $98K |
| **Total Assets** | $5.31M | $5.74M | $8.42M | $1.15M |
| Accounts Payable | $0 | $0 | $0 | $47K |
| Deferred Revenue (Current) | $133K | $142K | $202K | $185K |
| Other Current Liabilities | $967K | $934K | $691K | $775K |
| **Total Current Liabilities** | $1.33M | $1.32M | $755K | $2.38M |
| **Total Non-Current Liabilities** | $820K | $4.73M | $1.56M | $408K |
| **Total Liabilities** | $2.15M | $6.05M | $2.32M | $2.79M |
| **Total Debt (incl. Leases)** | $307K | $419K | $7.5K | $53K |
| Common Stock | $111K | $72K | $56K | $21K |
| Retained Earnings | -- | -- | -- | -$1.60M |
| Accumulated Other Comp. Income | -$34.89M | -$29.48M | -$18.42M | -$14.65M |
| **Total Stockholders' Equity** | $3.16M | -$312K | $6.11M | -$1.64M |
| Total Equity | $3.16M | -$312K | $6.11M | -$1.64M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.16M | $4.18M | $7.43M | $90K |
| Short-Term Investments | $2.00M | -- | -- | -- |
| **Cash & Short-Term Investments** | $4.20M | $4.18M | $7.43M | $90K |
| Accounts Receivable, Net | $185K | $115K | $22K | $184K |
| Inventory | $204K | $394K | $264K | $305K |
| Other Current Assets | $283K | $422K | $652K | $180K |
| **Total Current Assets** | $4.83M | $5.11M | $8.37M | $1.05M |
| Property, Plant & Equipment, Net | $106K | $108K | $50K | $41K |
| **Total Non-Current Assets** | $473K | $628K | $58K | $98K |
| **Total Assets** | $5.31M | $5.74M | $8.42M | $1.15M |
| Accounts Payable | $0 | $0 | $0 | $47K |
| Deferred Revenue (Current) | $133K | $142K | $202K | $185K |
| Other Current Liabilities | $967K | $934K | $691K | $775K |
| **Total Current Liabilities** | $1.33M | $1.32M | $755K | $2.38M |
| **Total Non-Current Liabilities** | $820K | $4.73M | $1.56M | $408K |
| **Total Liabilities** | $2.15M | $6.05M | $2.32M | $2.79M |
| **Total Debt (incl. Leases)** | $307K | $419K | $7.5K | $53K |
| Common Stock | $111K | $72K | $56K | $21K |
| Retained Earnings | -- | -- | -- | -$1.60M |
| Accumulated Other Comp. Income | -$34.89M | -$29.48M | -$18.42M | -$14.65M |
| **Total Stockholders' Equity** | $3.16M | -$312K | $6.11M | -$1.64M |
| Total Equity | $3.16M | -$312K | $6.11M | -$1.64M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$5.41M | -$11.05M | -$3.77M | -$1.65M | -$615K |
| Depreciation & Amortization | $29K | $23K | $17K | $18K | $18K |
| Stock-Based Compensation | $1.23M | $75K | $15K | $52K | -- |
| Change in Receivables | -$71K | -$92K | $162K | -$177K | -- |
| Change in Inventory | -$4.6K | -$244K | $7.0K | $34K | $6.7K |
| Change in Payables | -$68K | $128K | $9.4K | $10K | -$36K |
| **Operating Cash Flow** | -$5.80M | -$4.89M | -$2.94M | -$1.97M | -$986K |
| Capital Expenditure | -$28K | -$81K | -$26K | -$9.7K | -$5.6K |
| **Free Cash Flow** | -$5.83M | -$4.97M | -$2.96M | -$1.98M | -$991K |
| **Investing Cash Flow** | -$2.04M | -$149K | -$26K | -$9.7K | -$5.6K |
| **Financing Cash Flow** | $5.81M | $1.82M | $10.30M | $2.04M | $911K |
| **Net Change in Cash** | -$2.02M | -$3.25M | $7.34M | $57K | -$81K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 4.8% | 6.3% | 23.2% | 39.7% | 35.8% |
| **Operating Margin** | -721.1% | -597.1% | -451.2% | -328.3% | -136.3% |
| **Net Profit Margin** | -517.1% | -1185.9% | -607.8% | -295.1% | -85.0% |
| Return on Equity (ROE) | -171.5% | -- | -61.8% | -- | -- |
| Return on Assets (ROA) | -102.0% | -192.7% | -44.8% | -144.0% | -- |
| Current Ratio | 3.64x | 3.87x | 11.08x | 0.44x | -- |
| Quick Ratio | 3.48x | 3.57x | 10.73x | 0.31x | -- |
| Debt to Equity | 0.10x | -- | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +12.3% | +50.2% | +10.8% | -22.7% | -- |
| Gross Profit Growth (YoY) | -14.3% | -59.5% | -35.3% | -14.3% | -- |
| EPS Growth (YoY) | -68.7% | +28.6% | +57.1% | -71.3% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
